Vivimed Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE526G01021
  • NSEID: VIVIMEDLAB
  • BSEID: 532660
INR
22.75
-1.19 (-4.97%)
BSENSE

Dec 23

BSE+NSE Vol: 9.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Vivimed Labs Ltd stock-summary
stock-summary
Vivimed Labs Ltd
Micro Cap
Pharmaceuticals & Drugs
Vivimed Labs Ltd is engaged in manufacturing of Specialty Chemicals (mainly used in Personal Care and Cosmetic Industry), Pharmaceuticals, API's and Formulations. The company has strong presence in the areas of Health & Personal Care, Contract Research and Manufacturing. The company has four subsidiary companies, namely Creative Health Care Pvt Ltd, Vivimed Holdings Ltd (Hong Kong), Vivimed Labs Europe Ltd (UK) and Vivimed Labs USA Inc.
Company Coordinates stock-summary
Company Details
Plot No 78-A, Kolhar Industrial Area Bidar Karnataka : 585403
stock-summary
Tel: 91-8482-232045
stock-summary
yugandhar.kopparthi@vivimeslabs.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 16.58 Cr
Number of Shares
8.29 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
16-Apr-2019
8.29
16.58
390000
2
ESOP
03-Nov-2017
8.25
16.50
537500
2
ESOP
17-Apr-2017
8.2
16.40
967500
2
ESOP
17-Apr-2017
8.2
16.40
967500
2
ESOP
06-Apr-2016
8.1
16.20
64815132
2
Stock Split
06-Apr-2016
8.1
16.20
64815132
2
Stock Split
10-Sep-2013
1.62
16.20
142857
10
Allotment of Equity To Others
10-Sep-2013
1.62
16.20
142857
10
Allotment of Equity To Others
22-Mar-2013
1.61
16.06
2126984
10
Conversion of Preference Shares
22-Mar-2013
1.61
16.06
2126984
10
Conversion of Preference Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

37.0635

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (1.64%)

Promoter with highest holding

Bbr Projects Private Limited (11.45%)

Highest Public shareholder

Kitara Piin 1102 (9.37%)

Individual Investors Holdings

56.71%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Santosh Varalwar
Managing Director
60.0 lacs
V Manohar Rao
Whole Time Director
60.0 lacs
Subhash Varalwar
Non Executive Director
60.0 lacs
Sandeep Varalwar
Whole Time Director
60.0 lacs
S Raghunandan
Whole Time Director
50.0 lacs
M Bhagvanth Rao
Non Executive Independent Director
4.0 lacs
Nixon Patel
Non Executive Independent Director
50.0 k
Umanath Varahabhotla
Non Executive Independent Director
2.5 lacs
Yugandhar Kopparthi
Company Secretary & Compliance Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials and Consumables
1059.35
10%
 
10
Raw Materials and Consumables
90
Raw Materials and Consumables
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Speciality Chemicals
256.91
98.29%
Other Operating Income
4.48
1.71%
 
98.29
Speciality Chemicals
1.71
Speciality Chemicals
1.71
Other Operating Income
98.29
Other Operating Income
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
35 Cr
(Quarterly Results - Jun 2023)
Net Profit:
-16 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 189 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

9.51

stock-summary
Return on Equity

-833.41%

stock-summary
Price to Book

5.04